Karolin Trautmann‐Grill

1.2k total citations
38 papers, 389 citations indexed

About

Karolin Trautmann‐Grill is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Karolin Trautmann‐Grill has authored 38 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 12 papers in Pathology and Forensic Medicine and 11 papers in Genetics. Recurrent topics in Karolin Trautmann‐Grill's work include Platelet Disorders and Treatments (12 papers), Hemophilia Treatment and Research (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). Karolin Trautmann‐Grill is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Hemophilia Treatment and Research (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). Karolin Trautmann‐Grill collaborates with scholars based in Germany, Austria and United States. Karolin Trautmann‐Grill's co-authors include Martin Bornhäuser, Jan Moritz Middeke, Malte von Bonin, Uwe Platzbecker, Sebastian Tuve, Gerhard Ehninger, Anke Theil, Nona Shayegi, Carmen Wilhelm and Uta Oelschlägel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Karolin Trautmann‐Grill

25 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolin Trautmann‐Grill Germany 11 179 149 142 89 80 38 389
Pascaline Etancelin France 9 154 0.9× 72 0.5× 92 0.6× 125 1.4× 162 2.0× 27 360
Erminia Rinaldi Italy 5 139 0.8× 59 0.4× 194 1.4× 77 0.9× 73 0.9× 9 338
Francesco Autore Italy 11 94 0.5× 87 0.6× 79 0.6× 169 1.9× 113 1.4× 54 316
Tamara Berno Italy 11 168 0.9× 49 0.3× 148 1.0× 108 1.2× 59 0.7× 46 356
Gerjo A. Velders Netherlands 8 139 0.8× 159 1.1× 220 1.5× 133 1.5× 173 2.2× 15 453
Javier Pérez‐Calvo Spain 9 107 0.6× 122 0.8× 169 1.2× 85 1.0× 84 1.1× 16 398
Cécile Tomowiak France 11 131 0.7× 99 0.7× 99 0.7× 244 2.7× 189 2.4× 45 404
Elisabeth M. P. Steeghs Netherlands 12 193 1.1× 128 0.9× 114 0.8× 36 0.4× 43 0.5× 15 465
Lucas C. M. Arruda Sweden 16 121 0.7× 376 2.5× 145 1.0× 56 0.6× 254 3.2× 28 607
M. S. De Propris Italy 11 194 1.1× 151 1.0× 130 0.9× 156 1.8× 132 1.6× 16 432

Countries citing papers authored by Karolin Trautmann‐Grill

Since Specialization
Citations

This map shows the geographic impact of Karolin Trautmann‐Grill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolin Trautmann‐Grill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolin Trautmann‐Grill more than expected).

Fields of papers citing papers by Karolin Trautmann‐Grill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolin Trautmann‐Grill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolin Trautmann‐Grill. The network helps show where Karolin Trautmann‐Grill may publish in the future.

Co-authorship network of co-authors of Karolin Trautmann‐Grill

This figure shows the co-authorship network connecting the top 25 collaborators of Karolin Trautmann‐Grill. A scholar is included among the top collaborators of Karolin Trautmann‐Grill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolin Trautmann‐Grill. Karolin Trautmann‐Grill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobbelstein, Christiane, Robert Klamroth, Christina Hart, et al.. (2025). Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A. Blood Advances. 9(22). 5853–5860.
3.
Knöbl, Paul, Johannes Oldenburg, Ulrich J. Sachs, et al.. (2025). Detection of Anti-drug Antibodies in Patients with Acquired Hemophilia A: Data from the GTH-AHA-EMI Study. Hämostaseologie. 45. 1 indexed citations
4.
5.
Sachs, Ulrich J., Karolin Trautmann‐Grill, Christian Pfrepper, et al.. (2024). Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study. Research and Practice in Thrombosis and Haemostasis. 8(7). 102565–102565.
6.
Sockel, Katja, Katharina S. Götze, Christina Ganster, et al.. (2024). VEXAS syndrome: complete molecular remission after hypomethylating therapy. Annals of Hematology. 103(3). 993–997. 18 indexed citations
8.
Pezeshkpoor, Behnaz, Jens Müller, Bernd Pötzsch, et al.. (2024). Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study. Journal of Thrombosis and Haemostasis. 22(11). 3010–3034. 4 indexed citations
9.
Bröckelmann, Paul J., Peter Herhaus, Julia Meißner, et al.. (2023). Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial. Blood. 142(Supplement 1). 4456–4456.
10.
Pfrepper, Christian, Robert Klamroth, Johannes Oldenburg, et al.. (2023). Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group. Hämostaseologie. 44(6). 466–471. 10 indexed citations
11.
Matzdorff, Axel, Sonja Alesci, Johanna Gebhart, et al.. (2023). Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland. Oncology Research and Treatment. 46(Suppl. 2). 5–44. 13 indexed citations
12.
Trautmann‐Grill, Karolin, et al.. (2023). Treatment of Acquired von Willebrand Disease due to Extracorporeal Membrane Oxygenation in a Pediatric COVID-19 Patient with Vonicog Alfa: A Case Report and Literature Review. SHILAP Revista de lepidopterología. 7(1). e76–e81. 5 indexed citations
13.
Middeke, Jan Moritz, et al.. (2023). Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP. Blood Advances. 7(14). 3710–3724. 14 indexed citations
15.
Tiede, Andreas, Christina Hart, Paul Knöbl, et al.. (2023). Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study. The Lancet Haematology. 10(11). e913–e921. 28 indexed citations
16.
Matzdorff, Axel, Sonja Alesci, Johanna Gebhart, et al.. (2022). Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie. Oncology Research and Treatment. 46(Suppl. 1). 7–56.
17.
Haier, Jörg, Johannes Beller, Kristina Adorjan, et al.. (2022). Differences in Stakeholders’ Perception of the Impact of COVID-19 on Clinical Care and Decision-Making. Cancers. 14(17). 4317–4317. 3 indexed citations
18.
Trautmann‐Grill, Karolin, et al.. (2022). Diagnostik und Therapie klinisch relevanter paraneoplastischer Syndrome. Der Schmerz. 36(6). 447–457. 1 indexed citations
19.
Trautmann‐Grill, Karolin, Oliver Tiebel, Kristina Hölig, & Uwe Platzbecker. (2018). Erfolgreiche Behandlung einer erworbenen Hemmkörperhämophilie A mit rekombinantem porcinem Faktor VIII. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 114(8). 746–748. 2 indexed citations
20.
Teipel, Raphael, Falk Heidenreich, Julia Reinhardt, et al.. (2016). Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation. Bone Marrow Transplantation. 51(6). 793–798. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026